A collaborative investigation was completed by data innovations (manufacturer), (b)(4) (distributor) and (b)(6) health system (facility).Investigation with the facility determined that upon reviewing the assay package insert, the cutoff value in the configuration should be 500 ng/ml, not 1000 ng/ml.Because of this incorrect configuration value, results that were actually negative based on the 500 ng/ml value were being resulted as positive.This is not a malfunction of instrument manager medical device based on the incorrect value being configured in a rule at the facility.The facility is actively working on an investigation into identifying any potential patient impact.While this is not a malfunction of instrument manager medical device (rules were working as programmed), it is being reported due a patient impact statement not yet received by the facility due to the ongoing patient impact investigation.
|